Who makes AZD8566 IV carbon labelled?

AZD8566 IV carbon labelled is developed by AstraZeneca.

What development phase is AZD8566 IV carbon labelled in?

AZD8566 IV carbon labelled is in Phase 1.

Last reviewed 2026-04-23 · How we verify

AZD8566 IV carbon labelled

AstraZeneca · Phase 1 active Small molecule

At a glance

Generic name	AZD8566 IV carbon labelled
Sponsor	AstraZeneca
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AZD8566 IV carbon labelled CI brief — competitive landscape report
AZD8566 IV carbon labelled updates RSS · CI watch RSS
AstraZeneca portfolio CI